Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-26-008779

CVP,Strategy/Corp Development sold 48,900 shares at $103.05 ($5,039,311)

  • CVP,Strategy/Corp Development acquired 48,900 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BOBO DONALD E JR · CVP,Strategy/Corp Development

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-09 Exercise or conversion : show line 1 in the form 10b5-1 +48,900 $72.68 $3,554,052 71,698.25 D
2026-11-09 Sale : show line 2 in the form 10b5-1 −48,900 $103.05 $5,039,311 22,798.25 D
Open-market sales · 48,900 sh · avg $103.05 · $5,039,311

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-11-09 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) −48,900 0 D
Loading xslF345X06/doc4.xml…